Cookie Consent by PrivacyPolicies.com

February 4, 2022

The deployment of the Visual System of the HUTER Platform as well as the Digitalization Software for research images have been completed.

Date: February 4th 2022

The development of the activities regarding the HUTER Project Platform defined as “Visual system & Digitalization software” has been successfully completed. In our last report we provide an overview about the work performed as part of the “Platform integration”. The activities performed are divided in two main axes:


  • the visual interface of the platform and
  • the digitalization software developed.

The visual interface of the platform is mainly formed of visual interface of open tools that have been integrated in the platform as well as own developments.


The digitalization software includes specific libraries designed with the aim of transforming research images generated in HUTER into the digital imaging standard (DICOM).


BAHÍA Software S.L. will continue monitoring and implementing potential improvements and refinements if needed until the end of the project.


Access clicking here our last report to learn more


About the Human Uterus Cells Atlas – HUTER


The human uterus is a flagship reproductive organ with profound implications not only in reproduction but also in women´s health. HUTER can advance the Human Cell Atlas initiative for the exploitation potential in Obstetrics and Gynecology and biomedicine research areas such as Regenerative Medicine or Reproductive Medicine.


The uterus is itself a model for regenerative medicine since (i) endometrial tissue regenerates monthly and its transformation is executed through dynamic changes in states and interactions of multiple cell types, and (ii) myometrial tissue has remarkable regenerative capacity and extensive remodelling throughout pregnancy. Hence, the primary motivation HUTER proposal stems from the need to better understand the human uterus in order to more effectively address uterine diseases that impact women ́s health such as myomas or endometriosis and/or might contribute to infertility, infant and maternal mortality and morbidity such as preeclampsia.


HUTER technological and biological platform will be a crucial resource for the scientific and clinical communities to define the cellular basis of health and disease, allowing the rapid development of new diagnosis and prognosis tools and therapeutic advancements in the field.


Link to the project website: https://huter-hca.eu/